Page last updated: 2024-10-19

melatonin and Minimal Disease, Residual

melatonin has been researched along with Minimal Disease, Residual in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Analysis of residual tumor further revealed the depressed activity of MAPK, NF-kappa B, Wnt, and Hedgehog pathways and upregulated P53 pathway in tumors, which was in line with the inhibited tumor growth."3.01Melatonin enhances radiofrequency-induced NK antitumor immunity, causing cancer metabolism reprogramming and inhibition of multiple pulmonary tumor development. ( Abay, B; Chen, G; Chen, X; Fan, L; Hao, B; Li, M; Lin, S; Reiter, RJ; Ren, Y; Shi, Y; Xu, X; Yue, L; Zhang, M; Zheng, T, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, M1
Hao, B1
Zhang, M1
Reiter, RJ1
Lin, S1
Zheng, T1
Chen, X1
Ren, Y1
Yue, L1
Abay, B1
Chen, G1
Xu, X1
Shi, Y1
Fan, L1

Trials

1 trial available for melatonin and Minimal Disease, Residual

ArticleYear
Melatonin enhances radiofrequency-induced NK antitumor immunity, causing cancer metabolism reprogramming and inhibition of multiple pulmonary tumor development.
    Signal transduction and targeted therapy, 2021, 09-01, Volume: 6, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Animals; Cell Proliferation; Combined Modality Therapy; Female; Hedg

2021